Cargando…

A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders

BACKGROUND: Maternal depression and anxiety during pregnancy may enhance fetal exposure to glucocorticoids (GCs) and harm neurodevelopment. We tested whether a novel cross-tissue polyepigenetic biomarker indicative of in utero exposure to GC is associated with mental and behavioral disorders and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Suarez, Anna, Lahti, Jari, Lahti-Pulkkinen, Marius, Girchenko, Polina, Czamara, Darina, Arloth, Janine, Malmberg, Anni LK., Hämäläinen, Esa, Kajantie, Eero, Laivuori, Hannele, Villa, Pia M., Reynolds, Rebecca M., Provençal, Nadine, Binder, Elisabeth B., Räikkönen, Katri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739178/
https://www.ncbi.nlm.nih.gov/pubmed/33344728
http://dx.doi.org/10.1016/j.ynstr.2020.100275
_version_ 1783623277957087232
author Suarez, Anna
Lahti, Jari
Lahti-Pulkkinen, Marius
Girchenko, Polina
Czamara, Darina
Arloth, Janine
Malmberg, Anni LK.
Hämäläinen, Esa
Kajantie, Eero
Laivuori, Hannele
Villa, Pia M.
Reynolds, Rebecca M.
Provençal, Nadine
Binder, Elisabeth B.
Räikkönen, Katri
author_facet Suarez, Anna
Lahti, Jari
Lahti-Pulkkinen, Marius
Girchenko, Polina
Czamara, Darina
Arloth, Janine
Malmberg, Anni LK.
Hämäläinen, Esa
Kajantie, Eero
Laivuori, Hannele
Villa, Pia M.
Reynolds, Rebecca M.
Provençal, Nadine
Binder, Elisabeth B.
Räikkönen, Katri
author_sort Suarez, Anna
collection PubMed
description BACKGROUND: Maternal depression and anxiety during pregnancy may enhance fetal exposure to glucocorticoids (GCs) and harm neurodevelopment. We tested whether a novel cross-tissue polyepigenetic biomarker indicative of in utero exposure to GC is associated with mental and behavioral disorders and their severity in children, possibly mediating the associations between maternal prenatal depressive and anxiety symptoms and these child outcomes. METHODS: Children (n = 814) from the Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study were followed-up from birth to age 7.1–10.7 years. A weighted polyepigenetic GC exposure score was calculated based on the methylation profile of 24 CpGs from umbilical cord blood. Child diagnosis of mental and behavioral disorder (n = 99) and its severity, defined as the number of days the child had received treatment (all 99 had received outpatient treatment and 8 had been additionally in inpatient treatment) for mental or behavioral disorder as the primary diagnosis, came from the Care Register for Health Care. Mothers (n = 408) reported on child total behavior problems at child's age of 2.3–5.8 years and their own depressive and anxiety symptoms during pregnancy (n = 583). RESULTS: The fetal polyepigenetic GC exposure score at birth was not associated with child hazard of mental and behavioral disorder (HR = 0.82, 95% CI 0.54; 1.24, p = 0.35) or total behavior problems (unstandardized beta = −0.10, 95% CI -0.31; 0.10, p = 0.33). However, for one standard deviation decrease in the polyepigenetic score, the child had spent 2.94 (95%CI 1.59; 5.45, p < 0.001) more days in inpatient or outpatient treatment with any mental and behavioral disorder as the primary diagnosis. Criteria for mediation tests were not met. CONCLUSIONS: These findings suggest that fetal polyepigenetic GC exposure score at birth was not associated with any mental or behavioral disorder diagnosis or mother-rated total behavior problems, but it may contribute to identifying children at birth who are at risk for more severe mental or behavioral disorders.
format Online
Article
Text
id pubmed-7739178
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77391782020-12-18 A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders Suarez, Anna Lahti, Jari Lahti-Pulkkinen, Marius Girchenko, Polina Czamara, Darina Arloth, Janine Malmberg, Anni LK. Hämäläinen, Esa Kajantie, Eero Laivuori, Hannele Villa, Pia M. Reynolds, Rebecca M. Provençal, Nadine Binder, Elisabeth B. Räikkönen, Katri Neurobiol Stress Original Research Article BACKGROUND: Maternal depression and anxiety during pregnancy may enhance fetal exposure to glucocorticoids (GCs) and harm neurodevelopment. We tested whether a novel cross-tissue polyepigenetic biomarker indicative of in utero exposure to GC is associated with mental and behavioral disorders and their severity in children, possibly mediating the associations between maternal prenatal depressive and anxiety symptoms and these child outcomes. METHODS: Children (n = 814) from the Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study were followed-up from birth to age 7.1–10.7 years. A weighted polyepigenetic GC exposure score was calculated based on the methylation profile of 24 CpGs from umbilical cord blood. Child diagnosis of mental and behavioral disorder (n = 99) and its severity, defined as the number of days the child had received treatment (all 99 had received outpatient treatment and 8 had been additionally in inpatient treatment) for mental or behavioral disorder as the primary diagnosis, came from the Care Register for Health Care. Mothers (n = 408) reported on child total behavior problems at child's age of 2.3–5.8 years and their own depressive and anxiety symptoms during pregnancy (n = 583). RESULTS: The fetal polyepigenetic GC exposure score at birth was not associated with child hazard of mental and behavioral disorder (HR = 0.82, 95% CI 0.54; 1.24, p = 0.35) or total behavior problems (unstandardized beta = −0.10, 95% CI -0.31; 0.10, p = 0.33). However, for one standard deviation decrease in the polyepigenetic score, the child had spent 2.94 (95%CI 1.59; 5.45, p < 0.001) more days in inpatient or outpatient treatment with any mental and behavioral disorder as the primary diagnosis. Criteria for mediation tests were not met. CONCLUSIONS: These findings suggest that fetal polyepigenetic GC exposure score at birth was not associated with any mental or behavioral disorder diagnosis or mother-rated total behavior problems, but it may contribute to identifying children at birth who are at risk for more severe mental or behavioral disorders. Elsevier 2020-11-21 /pmc/articles/PMC7739178/ /pubmed/33344728 http://dx.doi.org/10.1016/j.ynstr.2020.100275 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Suarez, Anna
Lahti, Jari
Lahti-Pulkkinen, Marius
Girchenko, Polina
Czamara, Darina
Arloth, Janine
Malmberg, Anni LK.
Hämäläinen, Esa
Kajantie, Eero
Laivuori, Hannele
Villa, Pia M.
Reynolds, Rebecca M.
Provençal, Nadine
Binder, Elisabeth B.
Räikkönen, Katri
A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
title A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
title_full A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
title_fullStr A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
title_full_unstemmed A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
title_short A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
title_sort polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739178/
https://www.ncbi.nlm.nih.gov/pubmed/33344728
http://dx.doi.org/10.1016/j.ynstr.2020.100275
work_keys_str_mv AT suarezanna apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT lahtijari apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT lahtipulkkinenmarius apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT girchenkopolina apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT czamaradarina apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT arlothjanine apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT malmbergannilk apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT hamalainenesa apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT kajantieeero apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT laivuorihannele apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT villapiam apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT reynoldsrebeccam apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT provencalnadine apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT binderelisabethb apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT raikkonenkatri apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT suarezanna polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT lahtijari polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT lahtipulkkinenmarius polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT girchenkopolina polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT czamaradarina polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT arlothjanine polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT malmbergannilk polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT hamalainenesa polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT kajantieeero polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT laivuorihannele polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT villapiam polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT reynoldsrebeccam polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT provencalnadine polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT binderelisabethb polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders
AT raikkonenkatri polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders